A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT00267969 · COMPLETED
Trial details
- NCT number
- NCT00267969
- Sponsor
- Centocor Research & Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2006-07-01
- Enrollment
- 766
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.